Yinghong (Mimi) Wang

Tenure Professor at MD Anderson Cancer Center

Houston, Texas, United States

About

Dr. Wang has a strong academic background (M.D., Ph.D., M.Sc.) and profound clinical experience from world renowned medical programs (Johns Hopkins, Cleveland Clinic). She has broad research collaboration network worldwide and holds >100 peer-reviewed publications and numerous international conference presentations. Her specialized areas include Inflammatory Bowel Disease (IBD), fecal microbiota transplantation (FMT), and cancer immunotherapy induced gastrointestinal toxicities. Since joining MD Anderson in 12/2016, Dr. Wang has been recognized internationally for her expertise in managing cancer immunotherapy induced GI toxicities. She served as guideline panel member in multiple national and international oncology societies and gastroenterology societies (ASCO, SITC, NCCN, ESMO, AGA, ACG), UPTODATE immunotherapy GI toxicity chapter, and also the chair of MD Anderson institutional immunotherapy toxicity working group. She contributed two books as editor entitled “Managing Immunotherapy Related Organ Toxicities, A Practical Guide” in 09/2022 (https://link.springer.com/book/10.1007/978-3-031-00241-0), and "Challenging Cases in Immunotherapy Related Organ Toxicities" in 06/2025 (https://link.springer.com/book/10.1007/978-3-031-83533-9). Dr. Wang and her team achieved multiple breakthroughs of successful treatment for immunotherapy induced colitis refractory to standard treatment and published her pioneer work on many prestigious journals such as NEJM, JCO, Nature Medicine with great impact to this field. Dr. Wang and her team have launched three clinical trials in treating colitis and are actively enrolling patients (NCT03819296, NCT04038619, NCT04407247). Among them, two trials are offering FMT on a larger scale patient population to maximize the benefit and minimize the morbidities related to immunosuppressant use such as steroid. For your education on the immunotherapy induced colitis overview and treatment, please clink on the following link for PPT slides. URL: https://mediaplayer.mdanderson.edu/video-full/247F62CA-742A-4E64-A40F-42570B25A0DE.

Experience

  • MD Anderson Cancer Center (9 yrs 8 mos)
    • Deputy Division Head of Research, Division of Internal Medicine
      Sep 2025 - Present · 11 mos

    • Tenure Professor
      Aug 2024 - Present · 2 yrs

    • Chair of MD Anderson Immunotherapy Toxicity Working Group
      Sep 2019 - Present · 6 yrs 11 mos

  • Cleveland Clinic (8 yrs 5 mos)
    • Gastroenterologist
      Jul 2011 - Nov 2016 · 5 yrs 5 mos

    • Gastroenterology Fellow
      Jul 2008 - Jun 2011 · 3 yrs

  • Internal Medicine Resident at ALBANY MEDICAL CENTER
    Jul 2005 - Jun 2008 · 3 yrs